Real-Time European Filings API. Request Access
BIOMARIN PHARMACEUTICAL INC Logo

BIOMARIN PHARMACEUTICAL INC

Develops and commercializes therapies for rare, life-threatening genetic diseases.

BMRN | US

Overview

Corporate Details

ISIN(s):
US09061G1013
LEI:
Country:
United States of America
Address:
105 DIGITAL DRIVE, 94949 NOVATO
Website:
https://www.biomarin.com/
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioMarin Pharmaceutical Inc. is a global biotechnology company dedicated to developing and commercializing transformative therapies for rare and life-threatening genetic diseases. Founded in 1997, the company leverages its scientific expertise in the underlying causes of genetic conditions to create first-in-class and best-in-class treatments. Its portfolio of marketed products addresses disorders such as achondroplasia, severe hemophilia A, and various lysosomal storage diseases, often utilizing enzyme replacement therapies (ERTs) and other advanced modalities. BioMarin also maintains an active pipeline of investigational medicines in various stages of clinical and preclinical development to address unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOMARIN PHARMACEUTICAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOMARIN PHARMACEUTICAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BIOMARIN PHARMACEUTICAL INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

SOLIGENIX, INC. Logo
SOLIGENIX, INC.
Late-stage biopharma developing treatments for rare diseases and public health threats.
United States of America
SNGX
Sonnet BioTherapeutics Holdings, Inc. Logo
Sonnet BioTherapeutics Holdings, Inc.
Develops targeted cytokine therapies for cancer using a proprietary albumin-binding platform.
United States of America
SONN
Sonoma Pharmaceuticals, Inc. Logo
Sonoma Pharmaceuticals, Inc.
Develops and sells stabilized HOCl products for wound, skin, eye, nasal, and animal healthcare.
United States of America
SNOA
Sopharma AD Logo
Sopharma AD
Develops, manufactures, and distributes pharmaceuticals and generics in Bulgaria and regional markets.
Bulgaria
SFA
Spago Nanomedical AB Logo
Spago Nanomedical AB
Developing nanomedicines for precise cancer diagnosis and targeted radionuclide therapy.
Sweden
SPAGO
Spero Therapeutics, Inc. Logo
Spero Therapeutics, Inc.
Develops novel treatments for multi-drug resistant bacterial infections and rare diseases.
United States of America
SPRO
Spexis AG Logo
Spexis AG
Clinical-stage biopharma developing macrocyclic therapeutics for rare diseases and oncology.
Switzerland
SPEX
Sprint Bioscience Logo
Sprint Bioscience
Develops & out-licenses preclinical oncology drugs for difficult-to-treat cancers.
Sweden
SPRINT
SPRUCE BIOSCIENCES, INC. Logo
SPRUCE BIOSCIENCES, INC.
Developing first-in-class therapies for serious, underserved neurological conditions like MPS IIIB.
United States of America
SPRB
Spyre Therapeutics, Inc. Logo
Spyre Therapeutics, Inc.
Engineering advanced antibody therapies for IBD and other immune diseases.
United States of America
SYRE

Talk to a Data Expert

Have a question? We'll get back to you promptly.